Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis?Metjian A; Lim WHematology Am Soc Hematol Educ Program 2009[]; ä (ä): 247-9A 35-year-old female presents with a prolonged activated partial thromboplastin time (aPTT) on routine testing, which is found to be due to a lupus anticoagulant. She has no medical issues, no personal or family history of thrombosis, no history of pregnancy loss, and no symptoms suggestive of an underlying rheumatologic disorder. She is a non-smoker and does not take oral contraceptives. You are asked to provide recommendations regarding the need for primary thromboprophylaxis. As you begin your literature search, you formulate the following clinical question: "In asymptomatic patients with antiphospholipid antibodies, does primary prophylaxis prevent thrombotic complications?"|*Practice Guidelines as Topic[MESH]|Adult[MESH]|Anticoagulants/therapeutic use[MESH]|Aspirin/administration & dosage/therapeutic use[MESH]|Double-Blind Method[MESH]|Drug Therapy, Combination[MESH]|Evidence-Based Medicine[MESH]|Female[MESH]|Humans[MESH]|Hydroxychloroquine/administration & dosage/therapeutic use[MESH]|Incidental Findings[MESH]|Lupus Coagulation Inhibitor/*blood[MESH]|Partial Thromboplastin Time[MESH]|Primary Prevention/*standards[MESH]|Prospective Studies[MESH]|Randomized Controlled Trials as Topic[MESH]|Reference Values[MESH]|Thromboembolism/*prevention & control[MESH]|Thrombophilia/*drug therapy[MESH]|Unnecessary Procedures[MESH] |